Challenges in the classification of atrial fibrillation
暂无分享,去创建一个
Patrick T. Ellinor | Steven A. Lubitz | Valentin Fuster | Emelia J. Benjamin | V. Fuster | J. Ruskin | E. Benjamin | P. Ellinor | S. Lubitz | Jeremy N. Ruskin
[1] P. Wolf,et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.
[2] V. Fuster,et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation , 2001 .
[3] A. Belanger,et al. The Framingham study. , 1976, British medical journal.
[4] A. Capucci,et al. Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events , 2009, Journal of cardiovascular electrophysiology.
[5] P. Vestergaard,et al. Trends in incidence and mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark, 1980-1999. , 2005, International journal of cardiology.
[6] P. Petersen,et al. Embolic complications in paroxysmal atrial fibrillation. , 1986, Stroke.
[7] Dongfeng Qi,et al. The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study , 2009, Circulation. Arrhythmia and electrophysiology.
[8] Eric E. Smith,et al. Variants conferring risk of atrial fibrillation on chromosome 4q25 , 2007, Nature.
[9] G. Breithardt,et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[10] P. Wolf,et al. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. , 1985, JAMA.
[11] D. Henrion,et al. A 5-year prospective follow-up study in essential cryofibrinogenemia patients. , 2011, Autoimmunity reviews.
[12] Eric Boerwinkle,et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry , 2009, Nature Genetics.
[13] V. Santinelli,et al. Atrial fibrillation progression and management: a 5-year prospective follow-up study. , 2008, Heart rhythm.
[14] Frédéric Costes,et al. Frequent and Prolonged Asymptomatic Episodes of Paroxysmal Atrial Fibrillation Revealed by Automatic Long‐Term Event Recorders in Patients with a Negative 24‐Hour Holter , 2002, Pacing and clinical electrophysiology : PACE.
[15] M. Allessie,et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. , 1997, Circulation.
[16] W. W. Brabham. Valsartan for Prevention of Recurrent Atrial Fibrillation , 2010 .
[17] Samuel Wann,et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committ , 2006, European heart journal.
[18] B. Gersh,et al. Long-Term Progression and Outcomes With Aging in Patients With Lone Atrial Fibrillation: A 30-Year Follow-Up Study , 2007, Circulation.
[19] S. Lévy,et al. Classification system of atrial fibrillation. , 2000, Current opinion in cardiology.
[20] Ramon Brugada,et al. Short QT Syndrome and Atrial Fibrillation Caused by Mutation in KCNH2 , 2005, Journal of cardiovascular electrophysiology.
[21] R. Erbel,et al. Prediction of Conversion from Paroxysmal to Permanent Atrial Fibrillation , 2007, Pacing and clinical electrophysiology : PACE.
[22] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[23] John V. Wylie,et al. Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. , 2008, Archives of internal medicine.
[24] P. Schauerte,et al. Decreased Plasminogen Activator Inhibitor and Tissue Metalloproteinase Inhibitor Expression May Promote Increased Metalloproteinase Activity with Increasing Duration of Human Atrial Fibrillation , 2007, Journal of cardiovascular electrophysiology.
[25] G. Lip,et al. Depression, anxiety, and quality of life in patients with atrial fibrillation. , 2007, Chest.
[26] S. Nattel. New ideas about atrial fibrillation 50 years on , 2002, Nature.
[27] M. Pathy,et al. Atrial fibrillation and stroke in elderly hospitalized patients. , 1986, Age and ageing.
[28] E L Pritchett,et al. Observations on the transition from intermittent to permanent atrial fibrillation. , 2000, American heart journal.
[29] C. K. Madsen. A 30-Year Follow-Up Study of Actual Applied Music Practice versus Estimated Practice , 2004 .
[30] P Coumel,et al. Paroxysmal atrial fibrillation: a disorder of autonomic tone? , 1994, European heart journal.
[31] D. Levy,et al. Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop , 2009, Circulation.
[32] A. Camm,et al. Classification of Atrial Fibrillation , 1997, The American journal of cardiology.
[33] S. Lévy,et al. Paroxysmal atrial fibrillation: a need for classification. , 1995, Journal of cardiovascular electrophysiology.
[34] J. Halperin,et al. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. , 2000, Journal of the American College of Cardiology.
[35] D. Singer,et al. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. , 2008, Journal of the American College of Cardiology.
[36] R B D'Agostino,et al. Impact of atrial fibrillation on mortality, stroke, and medical costs. , 1998, Archives of internal medicine.
[37] R. Bubien,et al. Quality of life in patients with atrial fibrillation. , 1996, Cardiology clinics.
[38] Konomi Sakata,et al. Usefulness of P-wave dispersion in standard twelve-lead electrocardiography to predict transition from paroxysmal to persistent atrial fibrillation. , 2008, The American journal of cardiology.
[39] Cynthia A. Carnes,et al. C-Reactive Protein Elevation in Patients With Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation , 2001, Circulation.
[40] J. Ruskin,et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. , 2007, Heart rhythm.
[41] A. Raviele,et al. Antiarrhythmic Effect of Statin Therapy and Atrial Fibrillation A Meta-Analysis of Randomized Controlled Trials. , 2008, Journal of atrial fibrillation.
[42] Silvia G Priori,et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit , 2006, Journal of the American College of Cardiology.
[43] Stephen S. Cha,et al. Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence , 2006, Circulation.
[44] Massimo Santini,et al. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. , 2008, European heart journal.
[45] R. Page,et al. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. , 1994, Circulation.
[46] J. Halperin,et al. Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. , 1995, The American journal of cardiology.
[47] S. Saksena,et al. Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias. , 2007, American heart journal.
[48] Christopher Piorkowski,et al. Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation: Relevance of Asymptomatic Arrhythmia Recurrence , 2005, Circulation.
[49] Michael R. Rosen,et al. Pathophysiology and Prevention of Atrial Fibrillation , 2001, Circulation.
[50] J. Sage,et al. Risk of recurrent stroke in patients with atrial fibrillation and non‐valvular heart disease. , 1983, Stroke.
[51] Steven Swiryn,et al. Relationship between pattern of occurrence of atrial fibrillation and surface electrocardiographic fibrillatory wave characteristics. , 2004, Heart rhythm.
[52] S. Lévy,et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. , 1999, Circulation.
[53] G. Lip,et al. Quality of life in older people with atrial fibrillation , 2009, Journal of Interventional Cardiac Electrophysiology.
[54] Simon Stewart,et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. , 2002, The American journal of medicine.
[55] Walter E. Garrey. THE NATURE OF FIBRILLARY CONTRACTION OF THE HEART.—ITS RELATION TO TISSUE MASS AND FORM , 1914 .
[56] G. Lamas,et al. Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective , 2008, Journal of medical economics.
[57] P. Zimetbaum,et al. Quality of Life in Atrial Fibrillation: Measurement Tools and Impact of Interventions , 2008, Journal of cardiovascular electrophysiology.
[58] Salim Yusuf,et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. , 2007, Journal of the American College of Cardiology.
[59] A. Skanes,et al. A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF scale. , 2006, The Canadian journal of cardiology.
[60] M. Burns,et al. Case-Control Study , 2020, Definitions.
[61] David O. Martin,et al. Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study. , 2009, Heart rhythm.
[62] S. Yusuf,et al. Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis , 2005 .
[63] G. Lip,et al. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. , 2001, European heart journal.
[64] G. Lip,et al. A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation , 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[65] S Capewell,et al. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986--1996. , 2001, European heart journal.
[66] D. Todd,et al. Repetitive 4-Week Periods of Atrial Electrical Remodeling Promote Stability of Atrial Fibrillation: Time Course of a Second Factor Involved in the Self-Perpetuation of Atrial Fibrillation , 2004, Circulation.
[67] M. Rosenqvist,et al. Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF). , 2007, European heart journal.
[68] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.
[69] N. Kouchoukos,et al. Characterization of Atrial Fibrillation in Man: Studies Following Open Heart Surgery * , 1978, Pacing and clinical electrophysiology : PACE.
[70] Denis Roy,et al. Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation. , 1986, American heart journal.
[71] M. Wallander,et al. Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK , 2005, BMC cardiovascular disorders.
[72] T. Savides,et al. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. , 1989, The American journal of cardiology.
[73] L. Fauchier,et al. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. , 2008, Journal of the American College of Cardiology.
[74] Matthew Reynolds,et al. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[75] E. Maltezos,et al. Circulating levels of collagen type I degradation marker depend on the type of atrial fibrillation. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[76] G. Lip,et al. Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation. , 2007, Chest.
[77] G. Lip,et al. Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation. , 2009, Journal of psychosomatic research.
[78] M. Allessie,et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.
[79] J. Murabito,et al. Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality The Framingham Heart Study , 2003, Circulation.
[80] C. Israel,et al. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. , 2004, Journal of the American College of Cardiology.
[81] Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial Fibrillation , 2008, Stroke.
[82] F. Morady,et al. Prevalence and Characteristics of Continuous Electrical Activity in Patients with Paroxysmal and Persistent Atrial Fibrillation , 2008, Journal of cardiovascular electrophysiology.
[83] J. Seward,et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. , 2008, European heart journal.
[84] B. Gersh,et al. The natural history of lone atrial fibrillation. A population-based study over three decades. , 1987, The New England journal of medicine.
[85] F. Humar,et al. Lone atrial fibrillation: prognostic differences between paroxysmal and chronic forms after 10 years of follow-up. , 1999, American heart journal.
[86] Gregory Y H Lip,et al. Quality of life in patients with atrial fibrillation: a systematic review. , 2006, The American journal of medicine.
[87] M. Rosenqvist,et al. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. , 2010, European heart journal.
[88] M. Allessie,et al. High-density mapping of electrically induced atrial fibrillation in humans. , 1994, Circulation.
[89] A R Feinstein,et al. Risk for systemic embolization of atrial fibrillation without mitral stenosis. , 1990, The American journal of cardiology.
[90] Silvia G. Priori,et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .
[91] F. Gaita,et al. Different patterns of atrial activation in idiopathic atrial fibrillation: simultaneous multisite atrial mapping in patients with paroxysmal and chronic atrial fibrillation. , 2001, Journal of the American College of Cardiology.
[92] R B D'Agostino,et al. Secular trends in the prevalence of atrial fibrillation: The Framingham Study. , 1996, American heart journal.
[93] P. Gates,et al. Asymptomatic cerebral infarction in patients with chronic atrial fibrillation. , 1988, Stroke.
[94] S. Lévy,et al. Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. , 1998, European heart journal.
[95] S. Connolly,et al. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. , 2005, American Heart Journal.
[96] Therapy for atrial fibrillation: control of the ventricular response and prevention of recurrence. , 1995, Coronary artery disease.
[97] A. Laupacis,et al. Population rates of hospitalization for atrial fibrillation/flutter in Canada. , 2004, The Canadian journal of cardiology.
[98] Robby Nieuwlaat,et al. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. , 2010, Journal of the American College of Cardiology.
[99] Samuel Wann,et al. [Guidelines for the management of patients with atrial fibrillation. Executive summary]. , 2006, Revista espanola de cardiologia.
[100] D. Singer,et al. Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study. , 1991, The American journal of medicine.
[101] J. Nerbonne,et al. Atrial L-type Ca2+ currents and human atrial fibrillation. , 1999, Circulation research.
[102] T. Yamashita,et al. Progressive nature of paroxysmal atrial fibrillation. Observations from a 14-year follow-up study. , 2004, Circulation journal : official journal of the Japanese Circulation Society.
[103] S. Mouly,et al. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. , 2007, The Cochrane database of systematic reviews.
[104] J Fujii,et al. Clinical features of paroxysmal atrial fibrillation. An observation of 94 patients. , 1981, Japanese heart journal.
[105] M. Gollob,et al. Impact of genetic discoveries on the classification of lone atrial fibrillation. , 2010, Journal of the American College of Cardiology.
[106] James B Seward,et al. The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades. , 2003, Journal of the American College of Cardiology.
[107] C. Gieger,et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke , 2009, Nature Genetics.
[108] S. Saksena,et al. Relationship between atrial tachyarrhythmias and symptoms. , 2005, Heart rhythm.
[109] A. Skanes,et al. Validation of a New Simple Scale to Measure Symptoms in Atrial Fibrillation: The Canadian Cardiovascular Society Severity in Atrial Fibrillation Scale , 2009, Circulation. Arrhythmia and electrophysiology.
[110] J. Agmon,et al. Diagnosis and characteristics of lone atrial fibrillation. , 1989, Chest.
[111] B. Gersh,et al. Effect of atrial fibrillation pattern on survival in a community-based cohort. , 2005, The American journal of cardiology.
[112] J. Halperin,et al. Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. , 1995, The American journal of cardiology.